gene

PARKINSON

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PARKINSON: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

9830Connections
0Hypotheses
13Analyses
50Outgoing
50Incoming

Summary

PARKINSON is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, regulates. Associated with ALS, ALZHEIMER'S, ALZHEIMER'S DISEASE. Connected to 2646 entities in the SciDEX knowledge graph.

View on Wiki →

🧬 Gene Info
Gene SymbolPARKINSON
Associated DiseasesALS, Addiction, Aging, Alzheimer, Alzheimer Disease
Known Drugs/CompoundsRAPAMYCIN, RESVERATROL, LEVODOPA
InteractionsFMR1, RB1CC1, PARL, EIF2S1, NEURODEGENERATIVE DISEASES, ALS
KG Connections6056 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

Clinical Management Guide for CBS/PSP

therapeutic · 15224 words

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

Pathway Diagram

graph TD
    subgraph Pathology["Pathology"]
        PARKINSON["PARKINSON"] -->|"associated with"| ALS["ALS"]
        PARKINSON["PARKINSON"] -->|"associated with"| Parkinson["Parkinson"]
        PARKINSON["PARKINSON"] -->|"associated with"| CANCER["CANCER"]
        PARKINSON["PARKINSON"] -->|"associated with"| AGING["AGING"]
        PARKINSON["PARKINSON"] -->|"associated with"| Aging["Aging"]
        PARKINSON["PARKINSON"] -->|"associated with"| Alzheimer["Alzheimer"]
        PARKINSON["PARKINSON"] -->|"associated with"| Cancer["Cancer"]
        PARKINSON["PARKINSON"] -->|"associated with"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
        PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"associated with"| PARKINSON["PARKINSON"]
        OXIDATIVE_STRESS["OXIDATIVE STRESS"] -->|"associated with"| PARKINSON["PARKINSON"]
        APOPTOSIS["APOPTOSIS"] -->|"associated with"| PARKINSON["PARKINSON"]
    end
    subgraph Interactions["Interactions"]
        PARKINSON["PARKINSON"] -->|"interacts with"| Parkinson_1["Parkinson"]
    end
    subgraph Signaling["Signaling"]
        PARKINSON_S_DISEASE_2["PARKINSON'S DISEASE"] -.->|"inhibits"| PARKINSON["PARKINSON"]
        PARKINSON_S_DISEASE_3["PARKINSON'S DISEASE"] -->|"regulates"| PARKINSON["PARKINSON"]
        PARKINSON_S_DISEASE_4["PARKINSON'S DISEASE"] -->|"activates"| PARKINSON["PARKINSON"]
    end
    style PARKINSON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style ALS fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Parkinson fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Parkinson_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style CANCER fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AGING fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Aging fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Alzheimer fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Cancer fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NEURODEGENERATIVE_DISEASES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PARKINSON_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style OXIDATIVE_STRESS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PARKINSON_S_DISEASE_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PARKINSON_S_DISEASE_3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PARKINSON_S_DISEASE_4 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOPTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (4435)

TargetRelationTypeStr
ALSassociated_withdisease1.00
Parkinsonassociated_withdisease1.00
Parkinsoninteracts_withdisease1.00
CANCERassociated_withgene1.00
AGINGassociated_withgene1.00

Incoming (5395)

SourceRelationTypeStr
PARKINSON'S DISEASEassociated_withgene1.00
OXIDATIVE STRESSassociated_withgene1.00
PARKINSON'S DISEASEinhibitsgene1.00
PARKINSON'S DISEASEregulatesgene1.00
PARKINSON'S DISEASEactivatesgene1.00

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (13)

Scientific analyses that reference this entity

Why does iron chelation therapy worsen outcomes in H63D HFE variant carriers des

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.586

How do oligodendrocytes initiate neuroinflammation in PD when microglia are trad

neuroinflammation | 2026-04-13 | 2 hypotheses Top: 0.632

What molecular mechanisms underlie Atremorine's dramatic dopamine enhancement in

neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.467

Are autophagy-lysosome defects primary drivers or downstream consequences in spo

neurodegeneration | 2026-04-10 | 0 hypotheses

Senescent cell clearance as neurodegeneration therapy

neurodegeneration | 2026-04-04 | 0 hypotheses

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found